FBLG Stock Analysis: Buy, Sell, or Hold?
FBLG - FibroBiologics, Inc. Common Stock
$2.32
2.12 (1080.06%)
▲
5d:
+828.37%
30d:
+606.03%
90d:
+831.73%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 13, 2026
Get Alerted When FBLG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: FBLG is 527.0% above fair value ($0.37). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: FBLG is 527.0% above fair value ($0.37). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: FBLG is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $0.24 to $0.37.
Technical Outlook: Technically, FBLG is showing sideways momentum. Immediate support is located at $0.18, while resistance sits at $3.96. The stock is showing strong short-term momentum, up 1080.1% recently.
Market Sentiment: FBLG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+1934.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBLG is showing sideways momentum. Immediate support is located at $0.18, while resistance sits at $3.96. The stock is showing strong short-term momentum, up 1080.1% recently.
Market Sentiment: FBLG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+1934.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.24 -
$0.37
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+1080.1%)
- BULLISH: Trading 1934.6% below Wall St target ($4.00)
- WARNING: Recommendation downgraded due to 527.0% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.24 -
$0.37
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$3.97
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$4.00
(+1934.6%)
Share & Embed Analysis
Last updated: March 30, 2026 2:46 PM ET
Data refreshes hourly during market hours. Next update: 3:46 PM
Data refreshes hourly during market hours. Next update: 3:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBLG showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Hamid Khoja
BUY
30000 shares
2026-03-04
Pete O'heeron
BUY
15872 shares
2026-03-04
Pete O'heeron
BUY
18200 shares
2026-03-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 49 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 57 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$43 | 56 HOLD |
